About Us

---

Hinge Bio, Inc. is leveraging its proprietary Flex-Hinge antibody platform to develop the next-generation of multi-functional antibodies and Fc-fusion proteins that bind targets with multi-handed cooperativity.  Hinge Bio’s streamlined non-peptidyl linkage technology enables the production of therapeutic candidates with orders-of-magnitude improved affinity, specificity and biological activity, incorporating virtually any polypeptides, including gold standard targeting domains such as natural, unmodified Fabs and/or receptors, as well as effector molecules including agonists, cytokines and growth factors.